WHO GRADE 2 GLIOMA

Clinical trials for WHO GRADE 2 GLIOMA explained in plain language.

Never miss a new study

Get alerted when new WHO GRADE 2 GLIOMA trials appear

Sign up with your email to follow new studies for WHO GRADE 2 GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1

New hope for Hard-to-Treat cancers: olaparib targets IDH mutations

Disease control Ongoing

This study tests the drug olaparib in people with advanced solid tumors (including brain tumors and bile duct cancer) that have IDH1 or IDH2 mutations. The goal is to see if olaparib can shrink or slow the growth of these cancers. About 89 participants will receive the drug, and …

Matched conditions: WHO GRADE 2 GLIOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated May 17, 2026 05:34 UTC

WHO GRADE 2 GLIOMA

Get alerted when new WHO GRADE 2 GLIOMA trials appear

New hope for Hard-to-Treat cancers: olaparib targets IDH mutations